GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Cyclically Adjusted Book per Share

PharmaLundensis AB (XSAT:PHAL) Cyclically Adjusted Book per Share : kr0.38 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PharmaLundensis AB's adjusted book value per share for the three months ended in Mar. 2024 was kr0.050. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.38 for the trailing ten years ended in Mar. 2024.

During the past 12 months, PharmaLundensis AB's average Cyclically Adjusted Book Growth Rate was -13.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of PharmaLundensis AB was 2.30% per year. The lowest was -0.80% per year. And the median was 0.75% per year.

As of today (2024-06-10), PharmaLundensis AB's current stock price is kr0.642. PharmaLundensis AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr0.38. PharmaLundensis AB's Cyclically Adjusted PB Ratio of today is 1.69.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaLundensis AB was 2.08. The lowest was 0.00. And the median was 0.00.


PharmaLundensis AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for PharmaLundensis AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Cyclically Adjusted Book per Share Chart

PharmaLundensis AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.41 0.42 0.45 0.40

PharmaLundensis AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.43 0.41 0.40 0.38

Competitive Comparison of PharmaLundensis AB's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, PharmaLundensis AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaLundensis AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's Cyclically Adjusted PB Ratio falls into.



PharmaLundensis AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaLundensis AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.05/132.2054*132.2054
=0.050

Current CPI (Mar. 2024) = 132.2054.

PharmaLundensis AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.434 100.432 0.571
201409 0.365 100.161 0.482
201412 0.576 100.225 0.760
201503 0.542 99.950 0.717
201506 0.486 99.995 0.643
201509 0.429 100.228 0.566
201512 0.728 100.276 0.960
201603 0.654 100.751 0.858
201606 0.589 101.019 0.771
201609 0.540 101.138 0.706
201612 0.462 102.022 0.599
201703 0.766 102.022 0.993
201706 0.696 102.752 0.896
201709 0.636 103.279 0.814
201712 0.324 103.793 0.413
201803 0.276 103.962 0.351
201806 0.310 104.875 0.391
201809 0.263 105.679 0.329
201812 0.300 105.912 0.374
201903 0.252 105.886 0.315
201906 0.264 106.742 0.327
201909 0.222 107.214 0.274
201912 0.218 107.766 0.267
202003 0.190 106.563 0.236
202006 0.154 107.498 0.189
202009 0.133 107.635 0.163
202012 0.105 108.296 0.128
202103 0.162 108.360 0.198
202106 0.139 108.928 0.169
202109 0.118 110.338 0.141
202112 0.101 112.486 0.119
202203 0.062 114.825 0.071
202206 0.092 118.384 0.103
202209 0.074 122.296 0.080
202212 0.052 126.365 0.054
202303 0.097 127.042 0.101
202306 0.073 129.407 0.075
202309 0.046 130.224 0.047
202312 0.075 131.912 0.075
202403 0.050 132.205 0.050

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


PharmaLundensis AB  (XSAT:PHAL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PharmaLundensis AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.642/0.38
=1.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaLundensis AB was 2.08. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PharmaLundensis AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaLundensis AB (XSAT:PHAL) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Medicon Village, Scheelevagen 2, Lund, SWE, 22381
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB (XSAT:PHAL) Headlines

No Headlines